Total Clarity Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-2,144
Closed -$192K – 668
2022
Q2
$192K Hold
2,144
– – 0.1% 209
2022
Q1
$238K Buy
2,144
+113
+6% +$11.9K 0.13% 193
2021
Q4
$210K Sell
2,031
-1,086
-35% -$126K 0.1% 209
2021
Q3
$391K Buy
3,117
+467
+18% +$60.4K 0.19% 128
2021
Q2
$329K Hold
2,650
– – 0.18% 148
2021
Q1
$313K Sell
2,650
-550
-17% -$64.5K 0.18% 130
2020
Q4
$375K Buy
3,200
+810
+34% +$89.2K 0.26% 99
2020
Q3
$248K Buy
+2,390
New +$240K 0.22% 108
2020
Q1
– Sell
-1,900
Closed -$216K – 401
2019
Q4
$216K Buy
+1,900
New +$208K 0.16% 118

Other funds holding MDT

Total Clarity Wealth Management's MDT Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Medtronic (MDT) in Q3 2022, closing a stake of 2,144 shares — an estimated $192K sold.

Total Clarity Wealth Management first reported a position in MDT in Q4 2019 and held it in 9 quarters. The position peaked at $391K in Q3 2021. 1,931 funds tracked by Wall St. Rank hold MDT as of Q3 2022.

  • Total Clarity Wealth Management reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
  • Total Clarity Wealth Management sold 2,144 Medtronic shares in Q3 2022, an estimated $192K.
  • Total Clarity Wealth Management first reported a position in Medtronic in Q4 2019 and held it in 9 quarters.
  • Total Clarity Wealth Management's Medtronic position peaked at $391K in Q3 2021.
  • 1,931 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.